Amikacin News and Research

RSS
Manuka honey could cure serious lung infections caused by drug-resistant bacterium

Manuka honey could cure serious lung infections caused by drug-resistant bacterium

Rarely-used antibiotic could be a safe and affordable treatment for neonatal sepsis

Rarely-used antibiotic could be a safe and affordable treatment for neonatal sepsis

New drug cocktail offers hope to patients with highly drug-resistant tuberculosis

New drug cocktail offers hope to patients with highly drug-resistant tuberculosis

Scientists find a potent weapon against antibiotic resistance

Scientists find a potent weapon against antibiotic resistance

Powerful weapon discovered to fight antibiotic resistance in Staphylococcus aureus

Powerful weapon discovered to fight antibiotic resistance in Staphylococcus aureus

FDA approves manufacturing of Insmed's ARIKAYCE at Therapure Biopharma's Mississauga facility

FDA approves manufacturing of Insmed's ARIKAYCE at Therapure Biopharma's Mississauga facility

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

Insmed reports top-line data from Phase 3 study of new treatment in patients with NTM lung disease

Insmed reports top-line data from Phase 3 study of new treatment in patients with NTM lung disease

Understanding the rise in NTM infections

Understanding the rise in NTM infections

Study finds high rates of drug resistance to urinary tract infections in Bangladesh

Study finds high rates of drug resistance to urinary tract infections in Bangladesh

New analysis shows high mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium (NTM)

New analysis shows high mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium (NTM)

Novel rapid diagnostic test and shorter treatment with better outcomes may benefit MDR-TB patients

Novel rapid diagnostic test and shorter treatment with better outcomes may benefit MDR-TB patients

Researchers document accuracy of new tests for rapid diagnosis of drug-resistant forms of TB

Researchers document accuracy of new tests for rapid diagnosis of drug-resistant forms of TB

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

New TB-Profiler tool to find appropriate drugs for TB patients may improve likelihood of cure

New TB-Profiler tool to find appropriate drugs for TB patients may improve likelihood of cure

Bayer's Amikacin Inhale and Ciprofloxacin DPI receive QIDP designation from FDA

Bayer's Amikacin Inhale and Ciprofloxacin DPI receive QIDP designation from FDA

MOVANTIK tablets get FDA approval for treatment of OIC in patients with chronic, non-cancer pain

MOVANTIK tablets get FDA approval for treatment of OIC in patients with chronic, non-cancer pain

Researchers report that predominant CA-MRSA strain migrated from sub-Saharan Africa

Researchers report that predominant CA-MRSA strain migrated from sub-Saharan Africa

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Insmed reports results from ARIKAYCE phase 2 trial for treatment resistant NTM lung infections

Insmed reports results from ARIKAYCE phase 2 trial for treatment resistant NTM lung infections